Monthly Archives: December 2019

Phaco Training: Commentary by Partha Biswas and Sneha Batra on “Barrett’s Universal II formula: Time to change the old trends?”

Cataract surgery is the most commonly performed refractive surgery today. The last decade has seen a paradigm shift as phacoemulsification, better surgical skills, better machines, and more accurate biometric calculations have transformed cataract surgery from a simple vision-restoring surgery to a highly demanding refractive surgery. As more and more surgeries are being performed on patients… Read More »

Phaco Training: Commentary from IJO by Manisha Acharya, Abha Gour, Abhishek Dave titled “Tarsorrhaphy: A stitch in time”

Tarsorrhaphy is a simple option for accelerating the healing of corneal surface and is a useful tool for treating persistent epithelial defects (PEDs) secondary to exposure keratitis, neurotrophic keratopathy, and dry eye syndrome.[1] Generally, tarsorrhaphy is underused as a prophylaxis and treatment option for recalcitrant surface healing problems. Management of the neurotrophic cornea caused by damage… Read More »

Phaco Training: Michael W. Stewart MD of Mayo Clinic announces Novel oral therapy drug safe, effective for wet AMD

SAN FRANCISCO —Twice daily dosing of oral AKST4290 over the course of 6 weeks improved visual acuity in patients with neovascular age-related macular degeneration, according to a presenter at the American Academy of Ophthalmology annual meeting. “Further development of the drug is being planned [in] a randomized phase 2b study,” Michael W. Stewart, MD, professor and chairman of… Read More »